# A Phase I/Ⅱ Human Study of HY0001a for Injection in Adult Participants With Advanced Solid Tumors

Source: https://onco.cc/trials/nct07069062/  
OnCo record `nct07069062` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of Test product HY0001a for injection in advanced solid tumours, run by Sichuan Huiyu Pharmaceutical Co., Ltd, now recruiting.

## Summary

A Phase I/Ⅱ Human Study of HY0001a for Injection in Adult Participants With Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT07069062 by Sichuan Huiyu Pharmaceutical Co., Ltd, with 261 participants planned, started 2025-07-21 and due to reach its primary completion in 2027-06. Interventions recorded: Test product HY0001a for injection.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07069062
- Phase: 1/2
- Setting: A Multicenter, Open-label Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Clinical Efficacy of HY0001a for Injection in Patients With Advanced Malignant Solid Tumors
- Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd
- Enrolled: 261

## Sources

- ClinicalTrials.gov NCT07069062: https://clinicaltrials.gov/study/NCT07069062

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)

---
JSON: https://onco.cc/api/v1/entities/nct07069062.json